GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (FRA:QIA) » Definitions » Sale Of Investment

Qiagen NV (FRA:QIA) Sale Of Investment : €1,083 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Sale Of Investment?

Qiagen NV's sale of investment for the three months ended in Mar. 2024 was €177 Mil. It means Qiagen NV gained €177 Mil from selling investments. Qiagen NV's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €1,083 Mil.

Compared with last quarter (€109 Mil in Dec. 2023 ), Qiagen NV gained more money from selling investments in Mar. 2024 (€177 Mil).


Qiagen NV Sale Of Investment Historical Data

The historical data trend for Qiagen NV's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Sale Of Investment Chart

Qiagen NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 356.49 170.04 318.21 833.63 1,165.10

Qiagen NV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 276.29 353.66 442.98 108.95 177.22

Qiagen NV Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1,083 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qiagen NV Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Qiagen NV (FRA:QIA) Business Description

Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).
Executives
Dr. Metin Colpan Supervisory Board

Qiagen NV (FRA:QIA) Headlines

No Headlines